| 000 | 01684 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513170513.0 | ||
| 264 | 0 | _c19990421 | |
| 008 | 199904s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/314678 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavey, R T | |
| 245 | 0 | 0 |
_aA randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cApr 1999 |
||
| 300 |
_a849-58 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 700 | 1 | _aChaitt, D G | |
| 700 | 1 | _aAlbert, J M | |
| 700 | 1 | _aPiscitelli, S C | |
| 700 | 1 | _aKovacs, J A | |
| 700 | 1 | _aWalker, R E | |
| 700 | 1 | _aFalloon, J | |
| 700 | 1 | _aPolis, M A | |
| 700 | 1 | _aMetcalf, J A | |
| 700 | 1 | _aMasur, H | |
| 700 | 1 | _aDewar, R | |
| 700 | 1 | _aBaseler, M | |
| 700 | 1 | _aFyfe, G | |
| 700 | 1 | _aGiedlin, M A | |
| 700 | 1 | _aLane, H C | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 179 _gno. 4 _gp. 849-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/314678 _zAvailable from publisher's website |
| 999 |
_c10028601 _d10028601 |
||